HomeComparePZRXQ vs DVY

PZRXQ vs DVY: Dividend Comparison 2026

PZRXQ yields 2000000.00% · DVY yields 3.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PZRXQ wins by $4.879226400974806e+39M in total portfolio value
10 years
PZRXQ
PZRXQ
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full PZRXQ calculator →
DVY
DVY
● Live price
3.46%
Share price
$151.41
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.0K
Annual income
$432.91
Full DVY calculator →

Portfolio growth — PZRXQ vs DVY

📍 PZRXQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPZRXQDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PZRXQ + DVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PZRXQ pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PZRXQ
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
DVY
Annual income on $10K today (after 15% tax)
$294.47/yr
After 10yr DRIP, annual income (after tax)
$367.97/yr
At 15% tax rate, PZRXQ beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PZRXQ + DVY for your $10,000?

PZRXQ: 50%DVY: 50%
100% DVY50/50100% PZRXQ
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PZRXQ buys
0
DVY buys
0
No recent congressional trades found for PZRXQ or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPZRXQDVY
Forward yield2000000.00%3.46%
Annual dividend / share$2.00$5.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$25.0K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$432.91
Total dividends collected$4.879195005460081e+39M$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PZRXQ vs DVY ($10,000, DRIP)

YearPZRXQ PortfolioPZRXQ Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,046$346.43+$200.00MPZRXQ
2$3,738,731,768,458$3,738,517,757,009.35$12,177$357.65+$3738731.76MPZRXQ
3$65,315,062,866,930,490$65,311,062,423,938,240.00$13,398$368.47+$65315062866.92MPZRXQ
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$14,715$378.89+$1066400830062625.00MPZRXQ
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$16,134$388.90+$16272182796453826560.00MPZRXQ
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$17,662$398.51+$2.3205424011366188e+23MPZRXQ
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$19,306$407.71+$3.0927990661046884e+27MPZRXQ
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$21,074$416.50+$3.8524105697352695e+31MPZRXQ
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$22,974$424.90+$4.484688260147987e+35MPZRXQ
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$25,015$432.91+$4.879226400974806e+39MPZRXQ

PZRXQ vs DVY: Complete Analysis 2026

PZRXQStock

PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.

Full PZRXQ Calculator →

DVYETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this PZRXQ vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PZRXQ vs SCHDPZRXQ vs JEPIPZRXQ vs OPZRXQ vs KOPZRXQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.